RFK’ Jr.’s Immunity to Scientific Evidence is Dangerous: Co-Director Comments
February 13th, 2025
As a physician with a long career in alternative medicine and who opposes pharmaceutical marketing, you might think I have a lot in common with Robert F Kennedy Jr. You’d be wrong. Dr. Adriane…
A Hard Look at Prescribing: Program Co-Director Comments on New Opioid Study
February 13th, 2025
This February, Program Co-Director Adriane Fugh-Berman and her colleague, Judy Butler, authored an article breaking down a new study on opioid prescribing and use disorders. According to the…
History Repeating? Program Co-Director Comments on “Non-Addictive” Pain Pill in The Washington Post
January 17th, 2025
This week, Dr. Adriane Fugh-Berman, Co-Director of the M.S. HAPI program, commented on a new pain pill set for FDA review this January. The drug is non-opioid and aims to be an alternative to…
Advocacy in Action: PharmedOut Organizes a Letter Challenging “Dangerous Disinformation”
December 17th, 2024
A recent STAT news article covers Program Co-Director Dr. Adriane Fugh-Berman’s organization, PharmedOut, which has organized a letter signed by multiple experts on women’s health “demanding that…
Deceptive Pharma Surveys: New Op-Ed by Dr. Fugh-Berman and Judy Butler
December 16th, 2024
Program Co-Director Adriane Fugh-Berman and Judy Butler recently published an op-ed in the Pittsburgh Post-Gazette on the dangers of deceptively-worded, pharma-funded surveys. According to their…
“80% of Adolescents” at Risk: The Hoya Features HAPI Seminar in New Article
December 13th, 2024
The Hoya, Georgetown’s student newspaper, published an article on a HAPI seminar featuring Dr. Charles Hillman on Physical Activity, Adiposity, and Brain Health in Children. The recap covers his…
“A New Dystopic Era”: Dr. Fugh-Berman on Pharmaceutical Companies Selling Direct
November 12th, 2024
Dr. Fugh-Berman and her colleague at PharmedOut, Judy Butler, have just published an opinion piece in STAT news on an alarming new pharmaceutical practice: selling prescription drugs directly to…
Peer Reviewers Made $1 Billion in 3 Years: Dr. Fugh-Berman Featured in MedPage Today on Medical Journal Financial Conflicts
October 31st, 2024
More than half of peer reviewers for four top medical journals received payments from drug and medical device manufacturers, totaling $1.06 billion, from 2020 to 2022, according to an analysis of…
Drug Company Tricks: Patricia Bencivenga ’21 publishes Op-Ed in the Pittsburgh Post-Gazette
October 24th, 2024
Patricia Bencivenga ’21 recently published an Op-Ed in the Pittsburgh Post Gazette alongside Judy Butler on “Drug company tricks: Gaslighting the worried well into becoming the worried sick.”…
